Allianz Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,700
| Closed | -$249K | – | 2212 |
|
|
2024
Q4 | $249K | Hold |
6,700
| – | – | ﹤0.01% | 2055 |
|
|
2024
Q3 | $325K | Buy |
6,700
+1,300
| +24% | +$57.1K | ﹤0.01% | 1969 |
|
|
2024
Q2 | $216K | Buy |
+5,400
| New | +$224K | ﹤0.01% | 2020 |
|
|
2023
Q3 | – | Sell |
-12,800
| Closed | -$736K | – | 2179 |
|
|
2023
Q2 | $736K | Sell |
12,800
-20,800
| -62% | -$922K | ﹤0.01% | 1638 |
|
|
2023
Q1 | $1.26M | Sell |
33,600
-24,145
| -42% | -$792K | ﹤0.01% | 1583 |
|
|
2022
Q4 | $1.62M | Buy |
57,745
+36,821
| +176% | +$1.07M | ﹤0.01% | 1353 |
|
|
2022
Q3 | $588K | Sell |
20,924
-10,085
| -33% | -$329K | ﹤0.01% | 1515 |
|
|
2022
Q2 | $1.08M | Buy |
31,009
+7,780
| +33% | +$278K | ﹤0.01% | 1649 |
|
|
2022
Q1 | $834K | Hold |
23,229
| – | – | ﹤0.01% | 1938 |
|
|
2021
Q4 | $541K | Sell |
23,229
-4,788
| -17% | -$97.9K | ﹤0.01% | 2167 |
|
|
2021
Q3 | $533K | Buy |
28,017
+226
| +0.8% | +$4.43K | ﹤0.01% | 2215 |
|
|
2021
Q2 | $561K | Buy |
27,791
+30
| +0.1% | +$565 | ﹤0.01% | 1986 |
|
|
2021
Q1 | $509K | Buy |
+27,761
| New | +$516K | ﹤0.01% | 1893 |
|
|
2020
Q2 | – | Sell |
-52,001
| Closed | -$772K | – | 2380 |
|
|
2020
Q1 | $772K | Sell |
52,001
-201
| -0.4% | -$3.5K | ﹤0.01% | 1894 |
|
|
2019
Q4 | $1.01M | Buy |
52,202
+730
| +1% | +$14K | ﹤0.01% | 2190 |
|
|
2019
Q3 | $1.02M | Sell |
51,472
-77,147
| -60% | -$1.61M | ﹤0.01% | 2122 |
|
|
2019
Q2 | $2.71M | Buy |
128,619
+3,247
| +3% | +$67.9K | ﹤0.01% | 1768 |
|
|
2019
Q1 | $2.56M | Buy |
125,372
+208
| +0.2% | +$4.66K | ﹤0.01% | 1755 |
|
|
2018
Q4 | $2.49M | Buy |
125,164
+14,699
| +13% | +$290K | ﹤0.01% | 1677 |
|
|
2018
Q3 | $2.13M | Buy |
110,465
+14,495
| +15% | +$258K | ﹤0.01% | 1912 |
|
|
2018
Q2 | $1.47M | Buy |
95,970
+16,058
| +20% | +$281K | ﹤0.01% | 2075 |
|
|
2018
Q1 | $1.5M | Sell |
79,912
-1,776
| -2% | -$33.4K | ﹤0.01% | 2052 |
|
|
2017
Q4 | $1.57M | Sell |
81,688
-125
| -0.2% | -$2.33K | ﹤0.01% | 2099 |
|
|
2017
Q3 | $1.46M | Buy |
81,813
+60
| +0.1% | +$987 | ﹤0.01% | 2113 |
|
|
2017
Q2 | $1.46M | Buy |
81,753
+130
| +0.2% | +$2.06K | ﹤0.01% | 2092 |
|
|
2017
Q1 | $1.18M | Sell |
81,623
-438
| -0.5% | -$6.89K | ﹤0.01% | 2185 |
|
|
2016
Q4 | $1.51M | Sell |
82,061
-13,598
| -14% | -$265K | ﹤0.01% | 2067 |
|
|
2016
Q3 | $1.81M | Buy |
95,659
+1,645
| +2% | +$29.9K | ﹤0.01% | 2023 |
|
|
2016
Q2 | $1.52M | Buy |
+94,014
| New | +$1.33M | ﹤0.01% | 2031 |
|
Other funds holding AMPH
EIP
BTW
Allianz Asset Management's AMPH Position: Q1 2025 in Review
Allianz Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 6,700 shares — an estimated $249K sold.
Allianz Asset Management first reported a position in AMPH in Q2 2016 and held it in 29 quarters. The position peaked at $2.71M in Q2 2019. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.
- Allianz Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- Allianz Asset Management sold 6,700 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $249K.
- Allianz Asset Management first reported a position in Amphastar Pharmaceuticals in Q2 2016 and held it in 29 quarters.
- Allianz Asset Management's Amphastar Pharmaceuticals position peaked at $2.71M in Q2 2019.
- 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.
Based on Allianz Asset Management's 13F filing for Q1 2025, filed 5 May 2025.